TrialBlood advances2019

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia.

Sarah Cooley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.